RU2004105035A - COMPOUNDS USEFUL FOR TREATING OR PREVENTING A DISEASE MEDIATED BY ALPHA-2B-ADRENOCEPTOR - Google Patents
COMPOUNDS USEFUL FOR TREATING OR PREVENTING A DISEASE MEDIATED BY ALPHA-2B-ADRENOCEPTOR Download PDFInfo
- Publication number
- RU2004105035A RU2004105035A RU2004105035/04A RU2004105035A RU2004105035A RU 2004105035 A RU2004105035 A RU 2004105035A RU 2004105035/04 A RU2004105035/04 A RU 2004105035/04A RU 2004105035 A RU2004105035 A RU 2004105035A RU 2004105035 A RU2004105035 A RU 2004105035A
- Authority
- RU
- Russia
- Prior art keywords
- benzenesulfonamide
- dimethylpyrimidin
- linear
- amino
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Claims (21)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30644901P | 2001-07-20 | 2001-07-20 | |
US60/306,449 | 2001-07-20 | ||
FI20011560A FI116940B (en) | 2001-07-20 | 2001-07-20 | New N-pyrimidinyl para-aminobenzenesulfonamide derivatives as Alpha-2B adrenoceptor antagonists, useful for treating e.g. coronary heart disease, myocardial infarction, angina, restenosis and hypertension |
FI20011560 | 2001-07-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2004105035A true RU2004105035A (en) | 2005-06-27 |
Family
ID=26161203
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2004105035/04A RU2004105035A (en) | 2001-07-20 | 2002-07-22 | COMPOUNDS USEFUL FOR TREATING OR PREVENTING A DISEASE MEDIATED BY ALPHA-2B-ADRENOCEPTOR |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1417182A1 (en) |
JP (1) | JP2004535467A (en) |
CA (1) | CA2454187A1 (en) |
HU (1) | HUP0401076A2 (en) |
IL (1) | IL159511A0 (en) |
MX (1) | MXPA04000615A (en) |
NZ (1) | NZ530366A (en) |
PL (1) | PL367040A1 (en) |
RU (1) | RU2004105035A (en) |
WO (1) | WO2003008387A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI118265B (en) * | 2004-01-15 | 2007-09-14 | Jurilab Ltd Oy | A method for detecting the risk of acute myocardial infarction and coronary heart disease |
WO2006100263A2 (en) | 2005-03-23 | 2006-09-28 | Klat Pharma Animal Health Gmbh | Use of amides of sulfadimidine for the treatment of intestinal diseases in veterinary science |
JP2021500366A (en) | 2017-10-24 | 2021-01-07 | バイエル・アクチエンゲゼルシヤフト | Substituted imidazopyridine amides and their use |
WO2020216669A1 (en) | 2019-04-23 | 2020-10-29 | Bayer Aktiengesellschaft | Phenyl-substituted imidazopyridine amides and use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2086544C1 (en) * | 1991-06-13 | 1997-08-10 | Хоффманн-Ля Рош АГ | Benzenesulfonamide derivatives of pyrimidine or their salts, pharmaceutical composition for treatment of diseases associated with endothelin activity |
US6150389A (en) * | 1994-07-11 | 2000-11-21 | Allergan Sales, Inc. | Comformationally rigid bicyclic and adamantane derivatives useful as α2 -adrenergic blocking agents |
KR20020080413A (en) * | 2000-02-11 | 2002-10-23 | 오와이 주반티아 팔마 리미티드 | Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor |
AU2001252612A1 (en) * | 2000-04-28 | 2001-11-12 | Sankyo Company, Limited | Ppargamma modulators |
-
2002
- 2002-07-22 MX MXPA04000615A patent/MXPA04000615A/en unknown
- 2002-07-22 CA CA002454187A patent/CA2454187A1/en not_active Abandoned
- 2002-07-22 RU RU2004105035/04A patent/RU2004105035A/en not_active Application Discontinuation
- 2002-07-22 EP EP02748902A patent/EP1417182A1/en not_active Withdrawn
- 2002-07-22 NZ NZ530366A patent/NZ530366A/en unknown
- 2002-07-22 IL IL15951102A patent/IL159511A0/en unknown
- 2002-07-22 HU HU0401076A patent/HUP0401076A2/en unknown
- 2002-07-22 WO PCT/FI2002/000643 patent/WO2003008387A1/en not_active Application Discontinuation
- 2002-07-22 JP JP2003513947A patent/JP2004535467A/en not_active Withdrawn
- 2002-07-22 PL PL02367040A patent/PL367040A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NZ530366A (en) | 2005-02-25 |
WO2003008387A1 (en) | 2003-01-30 |
HUP0401076A2 (en) | 2004-09-28 |
JP2004535467A (en) | 2004-11-25 |
IL159511A0 (en) | 2004-06-01 |
CA2454187A1 (en) | 2003-01-30 |
EP1417182A1 (en) | 2004-05-12 |
MXPA04000615A (en) | 2004-04-20 |
PL367040A1 (en) | 2005-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2007148217A (en) | Preparation of N-phenyl-2-pyrimidinamine derivatives | |
RU2003120798A (en) | NEW N- (Phenylsulfonyl) Glycine Derivatives and Their Use in Therapy | |
CA2516370C (en) | A process of preparing imatinib and imatinib prepared thereby | |
PT1551834E (en) | Substituted quinazolinone compounds | |
RU2003120512A (en) | ACTIVATORS OF ISOINDOLIN-1-ON-GLUCOKINASE | |
RU2009115784A (en) | Pyrazole [1,5-A] pyrimidine derivatives and their use in medicine | |
RU96104356A (en) | AMIDIN DERIVATIVES WITH ACTIVITY AGAINST NITROGEN OXIDE SYNTHETASIS (U) | |
RU2003116648A (en) | SUBSTITUTED IMIDAZOPYRIDINES | |
WO2016199906A1 (en) | Sulfonamide derivative and pharmaceutically acceptable acid addition salt thereof | |
RU2001132570A (en) | Urea-substituted imidazoquinolines | |
PE20021011A1 (en) | QUINAZOLINE DERIVATIVES AS INHIBITORS OF RHO-KINASE | |
RU2007108861A (en) | TRIFTOMETHYL SUBSTITUTED BENZAMIDES AS KINASE INHIBITORS | |
RU2009115963A (en) | Oxadiazole derivatives with anti-inflammatory and immuno-depressant properties | |
RU2005123807A (en) | TETRAHYDRO-4H-PYRIDO [1,2-A] PYRIMIDINES AND RELATED COMPOUNDS USEFUL AS HIV INTEGRAS INHIBITORS | |
RU2004120553A (en) | NICOTINAMIDE DERIVATIVES USEFUL AS P38 INHIBITORS | |
CN1500089A (en) | Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain | |
RU2005119633A (en) | ANTI-VIRUS NUCLEOSIDE DERIVATIVES | |
JP2012522003A5 (en) | ||
PE20060243A1 (en) | DERIVATIVES OF 4-AMINO INSUSTITUTED-5- (4-UREA-PHENYL) -PYRROLOTRIAZINE | |
RU2007111758A (en) | AMINO DERIVATIVES 7- AMINO-3-Phenyldihydropyrimido [4,5-D] PYRIMIDINONES, THEIR PRODUCTION AND APPLICATION AS PROTEINKINASE INHIBITORS | |
JP2013510886A5 (en) | ||
JP2008519783A5 (en) | ||
JP2002167387A (en) | 2-(7,8-dihydro-8-oxo-9h-purine-9-yl)aceticacid derivative | |
CA2444489A1 (en) | Benzimidazolone compounds | |
AR041563A1 (en) | DERIVATIVES OF QUINAZOLINONA WITH ANTAGONIST ACTIVITY OF THE HUMAN VANILLOID RECEIVER TYPE 1 (VR1) USEFUL AS ANTIHIPERALGESICAL AGENTS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20060915 |